InformationASTX-029 ASTX-029 is an orally bioavailable inhibitor of the extracellular signal-regulated kinases (ERK) 1 and 2 , with potential antineoplastic activity. ASTX-029 inhibits ERK-dependent tumor cell proliferation and survival.TargetsERK1 ; ERK2.
Specifications and Purity: ≥99%
Molecular Formula: C29H31ClFN5O5
Molecular Weight: 584.04
PubChem CID: 129053037
Isomeric SMILES: C[C@H](C(=O)N[C@H](CO)C1=CC(=CC(=C1)F)OC)N2CC3=C(C2=O)C=C(C=C3)C4=NC(=NC=C4Cl)NC5CCOCC5
- UPC:
- 12141914
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- A412596-50mg
- CAS:
- 2095719-92-7
- Product Size:
- 50mg
akash.verma@cenmed.com
(732) 447-1115





